Showing results (61-70 of 212) with videos related to
Sort By:
Pageof 22
Clinical Neuropharmacology|August 1, 1990
Immunoreactive beta-endorphin, cortisol, and growth hormone plasma levels in obsessive-compulsive disorderR Weizman, I Gil-Ad, H Hermesh, et al.Harefuah|June 23, 2001
[Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial]R Shiloh, A Weizman, N Weizer, et al.The Journal of Clinical Psychiatry|August 1, 1989
Catatonic signs in severe obsessive compulsive disorderH Hermesh, R A Hoffnung, D Aizenberg, et al.Acta Psychiatrica Scandinavica|February 1, 1990
Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatmentB Spivak, A Weizman, L Wolovick, et al.Biological Psychiatry|March 26, 1998
Recurrence pattern of serum creatine phosphokinase levels in repeated acute psychosisI Manor, H Hermesh, A Valevski, et al.Clinical Dysmorphology|October 18, 2003
Another adult with Meier-Gorlin syndrome--insights into the natural historyStavit A Shalev, Judith G HallGeneral Hospital Psychiatry|January 1, 1994
Chlorpromazine prophylaxis of steroid-induced psychosisM Bloch, E Gur, A ShalevAnnales Medico-Psychologiques|November 1, 1986
[The post-traumatic syndrome: 6 months after the trauma]A Shalev, M Kotler, S TyanoJournal of the National Cancer Institute|February 1, 1984
Lack of beta 2-microglobulin on the surface of canine transmissible venereal tumor cellsD Cohen, A Shalev, M KrupHarefuah|September 24, 2011
[Implementing mindfulness based therapies as part of the comprehensive treatments in the Beer Sheba Mental Health Center]O Arbel, A Shalev, Z KaplanPageof 22